Yu Jeong Choi
Overview
Explore the profile of Yu Jeong Choi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
273
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim J, Lim S, Hahn J, Jeong J, Park Y, Chun W, et al.
Korean Circ J
. 2025 Feb;
PMID: 39962964
Background And Objectives: Outcomes of deferring percutaneous coronary intervention (PCI) without invasive physiologic assessment for intermediate coronary lesions is uncertain. We sought to compare long-term outcomes between medical treatment and...
2.
Choi Y, Choi J, Kang Y, Shin S, Lee S, Choi J
Cancer Cell Int
. 2025 Jan;
25(1):16.
PMID: 39825397
Background: The prognosis of a plasma cell neoplasm (PCN) varies depending on the presence of genetic abnormalities. However, detecting sensitive genetic mutations poses challenges due to the heterogeneous nature of...
3.
Kim H, Shin S, Lee J, Kim I, Kim B, Kim H, et al.
Ann Lab Med
. 2024 Nov;
45(2):160-169.
PMID: 39497415
Background: mutations are associated with poor prognosis in myelodysplastic neoplasm (MDS) and AML. The updated 5th WHO classification and International Consensus Classification (ICC) categorize -mutated MDS and AML as unique...
4.
Kim N, Choi Y, Cho H, Jang J, Lee S, Song J, et al.
Blood Adv
. 2024 Aug;
8(19):5122-5125.
PMID: 39158088
No abstract available.
5.
Choi Y, Lee S, Kim Y, Shin S, Lee K
Br J Haematol
. 2024 Jul;
205(4):1632-1635.
PMID: 39073102
No abstract available.
6.
Choi Y, Kook H, Lee S, Song J, Choi J, Cheong J, et al.
Leuk Lymphoma
. 2024 Jul;
65(13):2040-2043.
PMID: 39072445
No abstract available.
7.
Kim S, Kim N, Choi Y, Lee S, Choi J, Shin S
Cancers (Basel)
. 2024 Jul;
16(13).
PMID: 39001529
Gene fusions are key drivers in acute leukemia, impacting diagnosis and treatment decisions. We analyzed 264 leukemia patients using targeted RNA sequencing with conventional karyotyping and reverse transcription polymerase chain...
8.
Kim N, Hahn S, Choi Y, Cho H, Chung H, Jang J, et al.
Cancer Cell Int
. 2024 May;
24(1):174.
PMID: 38764048
Introduction: Acute myeloid leukemia (AML) is a complex hematologic malignancy characterized by uncontrolled proliferation of myeloid precursor cells within bone marrow. Despite advances in understanding of its molecular underpinnings, AML...
9.
Choi Y, Kim Y, Park H, Kim D, Lee H, Kim Y, et al.
Ann Clin Microbiol Antimicrob
. 2024 Apr;
23(1):29.
PMID: 38581051
Background: The prevalence of multidrug-resistant tuberculosis (MDR-TB) among Korean tuberculosis patients is about 4.1%, which is higher than the OECD average of 2.6%. Inadequate drug use and poor patient compliance...
10.
Kim N, Choi Y, Lee S, Choi J, Lyu C, Shin S, et al.
Front Oncol
. 2024 Mar;
14:1365614.
PMID: 38544839
Background: Aplastic anemia (AA), characterized by hematopoietic stem cell deficiency, can evolve into different hematologic malignancies. Our understanding of the genetic basis and mechanisms of this progression remains limited. Methods:...